⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OPTH News
Optimi Health Corp. Common Shares
Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial
prnewswire.com
OPTH
Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial
globenewswire.com
OPTH
Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development
prnewswire.com
OPTH
Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development
globenewswire.com
OPTH
Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia
globenewswire.com
OPTH
Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia
prnewswire.com
OPTH
Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia
globenewswire.com
OPTH
Diamond Equity Research Initiates Coverage on Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN)
globenewswire.com
OPTH
Optimi Health Advances Highest-Purity Natural Psilocybin Extract to Date Ready to Announce with Confidence?
newsfilecorp.com
OPTH
Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting
prnewswire.com
OPTH